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Abstract 
TALPID3 (KIAA0586) is a centrosomal, protein which has specific functions during centriole 
maturation during the formation of the centrosomal dependent organelle, the cilia, as well as 
less well understood roles in the cytoskeleton and during cell polarisation. Cilia are an essential 
component of signal transduction during embryonic development and the loss of TALPID3 
function in humans can cause both severe lethal and mild cilia-related developmental disorders 
known as ‘ciliopathies’ the most common being Joubert syndrome. TALPID3 related 
ciliopathies affect the development of multiple organ systems including the brain, skeleton, 
eyes, lungs and liver. The consequences of TALPID3 dysfunction outside of the cilia and the 
implications for human diseases, is less well understood. 
 
Introduction 
When the talpid3 chicken mutant was first discovered by Donald Ede at Wye Agricultural 
College, UK in the 1960s, during a preliminary investigation into chick hatchability [1] it was 
never anticipated that this peculiar mutant would one day contribute to understanding rare 
  
human diseases. Fortuitously Dr Ede, a previous student of Prof. C.H. Waddington, was an 
excellent anatomist and developmental biologist, with a particular interest in embryonic lethal 
developmental mutants with a disruption of pattern [2].  Donald immediately understood the 
significance of the severely disrupted anatomy of the talpid3 embryos, which was particularly 
evident in the polydactylous limbs and head [3,4]. His work and the discovery of talpid3, came 
at a timely moment in developmental biology, just as the chicken limb was becoming an 
important paradigm for understanding the induction of pattern in the developing embryo, in 
fact preceding the discovery of the cellular ‘organiser’ of digit number and identity [4]. Talpid3 
was to play an important role in understanding the developmental mechanisms which pattern 
the developing limb and in turn, forty years later, research on polydactylous mice helped 
established that a loss of cilia underpinned the unusual talpid3 phenotype [4]. 
Talpid3 chicken embryos are characterised by gross malformations of the brain, face, skeleton 
and limbs and have been a focus of many studies over several decades, in an attempt to 
understand the basis of their aberrant anatomy [3,4]. The TALPID3 gene (also known as 
KIAA0586), has now also been deleted in different animal and cell models, generating a well 
defined catalogue defects that occur upon TALPID3 loss of function (Table 1, Figure 1A, B). 
Primarily, a loss of TALPID3 causes a failure of cilia formation [5,6] and thus TALPID3 
mutants fall into a class of developmental phenotypes known as ‘ciliopathies’. Cilia are 
centrosome dependent organelles which project from the cell surface (Figure 1A). Cilia can be 
both actively motile such as ependymal cell cilia which line the ventricles of the brain, or 
‘primary’ non-motile cilia, which are found on most cell types and are essential for some 
signalling pathways, in particular Hedgehog signalling (Figure 1A)[7]. Most recently, this in-
depth understanding of the TALPID3 phenotype has aided identification of human ciliopathy 
patients with mutations in TALPID3/KIAA0586 [8-16]. Analyses of TALPID3 at the molecular 
level, meanwhile, have revealed that this centrosomal protein [17] has a role within mother 
  
centriole maturation prior to initiation of ciliogenesis [18] although there is evidence that 
TALPID3 may also have other non-ciliary centrosomal roles such as within organisation of the 
polarised cytoskeleton. [5,6,15] as well as possible roles independent of the centrosome 
(Figure.1A). 
 
TALPID3- sequence, homology, domains and interactions 
Vertebrates have a single TALPID3 gene, encoding a centrosomal protein of between 1520-
1644aa (Figure 2), which localises specifically to the distal ends of both the mother and 
daughter centrioles which comprise the centrosome complex (Figure3A, 3C, C’, [5,17-21]). It 
is one of the least abundant centrosomal proteins [22] and has an asymmetrical distribution, 
being more highly localised on the mother centriole (Figure 3A,[21]). TALPID3 does not show 
homology to other protein families, and its structure remains elusive. While the TALPID3 
sequence is not highly conserved (the human TALPID3 protein is approximately 70% identical 
to mouse and 45% to chicken), TALPID3 proteins do contain conserved coiled coil domains 
approximately 450-650aa from the N’ terminal (Figure 2, pink boxes), one of which is essential 
for function and which mediates both localisation of TALPID3 to the centrosome and the 
majority of known TALPID3 protein-protein interactions [blue asterisk; 4,18,19, 21, 23-27]. 
Deletion of this domain causes a TALPID3 null phenotype in chicken, mice, zebrafish and 
human cells [5,18,19, 24, 27]. There is evidence that the TALPID3 coiled coil domains 
specifically mediate the maturation of the mother centriole through loss of daughter centriolar 
proteins and assembly of the basal body distal appendages prior to ciliogenesis [27]. A less 
well defined portion of C’terminal end of TALPID3 is also essential for function [5,27]. This 
region binds to the PKA regulatory subunit PKARIIβ, through which is it proposed to mediate 
Hedgehog signalling via PKA phosphorylation of the Gli proteins [28]. In addition the 
  
C’terminal may also mediate ciliogenesis through CP110 removal and ciliary vesicle docking 
[27]. 
 
A Ciliopathy- the TALPID3 Phenotype in Models and Man   
Other than a few species-dependent exceptions, the phenotypes of the TALPID3 null animal 
models are very similar. All are recessive and embryos homozygous for the TALPID3 
mutations lack cilia (including motile cilia) and are embryonic lethal (Table 1, Supplementary 
Table 1, Figure 1A);[1,5,19,24,28]. The developmental abnormalities exhibited by TALPID3 
null model embryos of all species, such as hypotelorism, holoprosencephaly, unpatterned 
polysyndactyly limbs and others (Table 1) are highly characteristic of vertebrate ciliopathy 
mutants which lack primary cilia and have disrupted Hedgehog signalling [7]. Since 2015 a 
number of human patients with mutations in TALPID3/KIAA0586 have been described 
providing an allelic series of TALPID3/KIAA058 mutations (Figure 2); [8-16]. In human 
patients rare homozygous mutations at c.230C>G, p.Ser77* (null) and c.1815G>A in 
KIAA0586 (the human ortholog of TALPID3), which appear to disrupt the TALPID3 protein 
before or around the essential coiled coil domain, cause a reduction of cilia on patient cells 
(c.1815G>A) and gestational and perinatal lethal phenotypes, respectively. Like the animal 
models, these null human alleles are associated with polydactyly and micromelia [9]. 
Additional phenotypes in these patients included cleft palate and hydrocephalus (c.230C>G, 
p.Ser77*), short ribs, abnormal tongue development and brain malformations (c.1815G>A), 
suggestive of Short-Rib Polydactyly ciliopathy syndrome. The similarity with the null 
TALPID3 animal models was unequivocal, demonstrating a conservation of 
TALPID3/KIAA0586 function in humans. 
  
The majority of human patients with mutations in TALPID3/KIAA0586, are however, viable 
and although they demonstrate challenging phenotypes associated with ciliopathy disorders 
these are at the mildest end of the ciliopathy spectrum [8, 10-15]. Joubert syndrome, the most 
common and mild syndrome in the ciliopathy spectrum caused by mutations in KIAA0586, is 
a genetically heterogenous disorder which can be caused by mutations in at least 34 different 
loci, including TALPID3/KIAA0586 (JBTS23; [29]. Diagnosis of Joubert syndrome is based 
on cerebellum and hindbrain malformations, specifically the ‘molar tooth sign’ observed on an 
axial MRI [Figure 1B. 29,30]. As the cerebellum is particularly susceptible to disruption in 
Hedgehog signalling [31], it is hypothesised that the molar tooth sign is due to a loss of 
Hedgehog dependent development of the cerebellar vermis resulting in fewer efferent fibres 
exiting the cerebellum via the paired superior cerebellar peduncles. Additionally it has also 
been proposed that there is a loss of decussation (crossing of the midline) of superior cerebellar 
peduncle neuronal tracts [29,30]. As the cerebellum normally coordinates voluntary 
movements such as posture, balance, coordination and speech as well as eye movement and 
breathing [31], common clinical characteristics associated with Joubert syndrome include 
hypotonia, abnormal eye movements, abnormal breathing patterns, slow speech, development 
and intellectual impairment [29] all of which have been described in patients with mutations in 
KIAA0586 [8,10-16]. In order to model Joubert syndrome through loss of Talpid3, a mouse 
with a conditional deletion of Talpid3 in the central nervous system, has recently been 
generated [32]. This had a surprisingly specific effect on the development of the cerebellum 
and little effect, other than hydrocephaly in the rest of the central nervous system. The 
phenotype of these mice closely recapitulated many aspects of Joubert syndrome [32]. As well 
as severe hypoplasia and a lack of foliation of the cerebellar hemispheres, there was loss of 
decussation of the superior cerebellar peduncles. In addition, both the Purkinje cell layer and 
the granule cell layer were affected by a loss of Talpid3; proliferation and normal organisation 
  
of granule layer cells were compromised, while the Purkinje cell layer demonstrated abnormal 
dendritic arborisation and a widespread disruption of the cerebellar circuitry [32]. This mouse 
model demonstrated significant ataxia, supporting its relevance as a model for Joubert 
syndrome, but happily the mice were able to both feed and groom. 
 
The TALPID3 Gene: a Genotype to Phenotype Conundrum  
Joubert syndrome is considered a pleiotropic condition and patients commonly exhibit other 
ciliopathy phenotypes including retinal dystrophy, kidney disease, coloboma, liver fibrosis, 
encephalocele and polydactyly [33]. Despite TALPID3/KIAA0586 null phenotype clearly 
acting pleiotropically in both human and animal models, Joubert syndrome caused by 
mutations in TALPID3/KIAA0586 is only rarely associated with other ciliopathy related 
phenotypes (Figure 1B). These include a limited number of examples of coloboma [10,16] 
atrial-septal defects [10,15] polydactyly, sensorineural hearing loss [10], skeletal dysplasia of 
the thorax [12] and mild respiratory and liver dysfunction [12]. The difference in severity of 
phenotypes both between the severe and mild ciliopathy phenotypes caused by 
TALPID3/KIAA0586 mutations as well as between different Joubert loci, may be due both to 
the heterogenous nature of the human mutations and/or to the tissue-specific requirements for 
TALPID3/KIAA0586, cilia or Hedgehog signalling. It is clear that mutations in the 5’ end of 
TALPID3/KIAA0586 are likely to cause a ciliopathy phenotype (Figure 2) and that mutations 
that disrupt the essential coiled-coil domain are more likely to cause a severe ciliopathy 
phenotypes, with the exception of the c.428delG p.Arg143Lysfs*4 mutations.  
The c.428delG p.Arg143Lysfs*4 mutation is a particularly prevalent mutation accounting for 
34/49 known compound heterozygous mutations, and while it would be predicted to disrupt 
the coiled coil domains causing a loss of TALPID3/KIAA0586 function, there are two reported 
  
cases of Joubert syndrome patients and one reported healthy individual, homozygous for the 
mutation [10,13,14]. This suggests the c.428delG p.Arg143Lysfs*4 mutation is instead likely 
to function as a hypomorphic allele, possibly through the use of an alternative start codon 
downstream of the c.428delG p.Arg143Lysfs*4 mutation which may produce a functional 
shortened protein (Figure 2, purple arrow; NM_001244193/NP_001231122); [13].  The 
disparity between the severe embryonic lethal phenotype observed in null TALPID3 embryos 
and the relativity mild Joubert phenotype observed in the majority of TALPID3/KIAA0586 
compound heterozygous mutations including those patients with a c.428delG 
p.Arg143Lysfs*4, support the hypothesis that this is a hypomorphic allele. TALPID3 is a low 
abundance protein [22] and the disparity between null and hypomorphic alleles perhaps 
suggests that very little active TALPID3 protein is required to fulfil its function in the cell.  
 
More than a Ciliopathy- TALPID3 in the Centrosome and Cytoskeleton 
The TALPID3 null phenotype is driven not only by a loss of cilia but by multiple mechanistic 
failures within the centrosome and possibly cytoskeleton, prior to ciliogenesis [5, 6, 15, 18, 26, 
27]. The centrosome is a highly complex, structured and dynamic organelle, comprising of two 
centrioles surrounded by centriolar material and the centriolar satellites [17,20]. The 
centrioles, known as the mother and daughter centrioles are structurally different  and have 
different and asymmetric protein compositions [20]. Centrioles lacking TALPID3 exhibit a 
number of abnormalities; TALPID3 null centrioles fail to migrate normally within the cell, are 
overly elongated, have a loss of orientation and are unable to dock with the ciliary vescile. 
Critically, in TALPID3 null cells, mother centrioles fails to undergo maturation prior to ciliary 
vesicle docking and ciliogenesis. Detailed analysis of this process has shown that centrioles 
lacking TALPID3 do not undertake removal of daughter centriolar proteins and subsequently 
  
also fail to acquire mother centriolar proteins during maturation, including normal Distal 
Appendage (DA) proteins and structure [Figure 3B; 5,6,18,27], although some disorganised 
DA proteins have been shown to be present in human and chicken TALPID3 null cells [9, 15]. 
In addition around the centrioles there is an increased number and disorganisation of the 
centriolar satellites. Increasingly the search to understand the biological function of TALPID3 
has turned to proteomics combined with super resolution microscopy and genome editing 
technology to assess the hierarchical and dynamic nature of TALPID3 protein interactions 
within the centrosome [27,34]. TALPID3 localises to the distal ends of both the mother and 
daughter centrioles and directly interacts with numerous centrosomal proteins including 
PCM1, MIB1, CP110, CEP290, CEP120, C2CD3, MACF1, CEP97/KIF24, RAB8a, PKARIIβ 
[18,21,25,26,27,28,34]. PCM1 is key controller of the abundance of TALPID3 on the mother 
centrioles by sequestering the E3 Ligase MIB1 to the centriolar satellites, which would 
otherwise promotes the poly-ubiquitylation of TALPID3. TALPID3 is recruited to the distal 
centrioles through reciprocal interactions with C2CD3 and CEP120; the loss of the any one of 
these two partners leads to a failure of ciliogenesis and Joubert syndrome [15, 34]. Once at the 
distal end of the mother centriole, TALPID3 and C2CD3 play a central role in the maturation 
of the mother centriole, controlling first the removal of daughter centriolar proteins and then 
the recruitment of proteins during the assembly of the DA [21,34] (Figure 3A). While the Sub 
Distal Appendage (SDA) appears to remain intact, TALPID3 is also known to interact with 
MACF1, a SDA protein and other proteins between the DA and SDA are mislocalised 
(CEP19). TALPID3 also interacts with CP110 which must be removed from the distal centriole 
to allow prior to the recruitment of ciliary vesicles, which is dependent on RAB8a (Figure 3A) 
[25, 27]. Recent papers [27,34] have utilised human TALPID3/KIAA0586 mutations to inform 
proteomic approaches to establish potential residues and uncharacterised domains that the 
TALPID3 protein used to control the dynamic and transient actions of the distal centriolar 
  
interacting protein network. The distinctive multiple roles of TALPID3 within the distal 
centriole are not generic to all proteins of the distal centriolar protein network- nor even 
TALPID3’s binding partners such as C2CD3. C2CD3 is a particularly interesting example; a 
null mutation in C2CD3 also causes an embryonic lethal chicken mutant, talpid2 [3]. While 
talpid3 and talpid2 have overlapping phenotypic features (polydactyly) and both cause a loss of 
OFD1 at the distal end of the centriole [27], they also have distinctive differences; hyperteloism 
in talpid2, hypoteloism in talpid3 [3]; a loss of TALPID3 causes elongation of the centrioles, 
while a loss of C2CD3 causes a shortening; TALPID3 null cells have an abnormal actin 
cytokeleton, while null C2CD3 cells do not [5, 34]. Thus while TALPID3 and C2CD3 have 
overlapping and co-ordinated functions they also have distinctive functions from each other, 
which lead to diverse phenotypes in null situations.  
Actin cytoskeleton defects are observed in both chickens and human TALPID3 null cells and 
TALPID3 null animal models also demonstrate cell polarity defects (Table1) [5, 27] including 
a recent demonstration of the disruption of cell polarity in photoreceptor cells [35]. The 
centrosome may also be nucleation centre for the actin cytoskeleton [40] but it is currently 
unknown whether the actin cytoskeleton is directly mediated by TALPID3, or perhaps through 
interactions with other proteins such a MACF1 (Microtubule Actin Crosslinking Factor 1; 
[25]). This is, however, an important distinction between the TALPID3 null phenotype and 
other ciliopathy mutants which have normal centrosomes but lack cilia for other reasons. While 
superficially ciliopathy phenotypes are overwhelming due to the loss of normal Hedgehog 
signalling, fundamentally the phenotype of TALPID3 null mutants is also underpinned by a 
different and abnormal cell biology, with different, although subtle consequences for the 
embryo and perhaps for patients.  
 
  
Conclusion 
The talpid3 legacy is far from complete. We have, as yet, only a partial understanding of the 
action of TALPID3 within the centrosome with hints that there are dynamic and multiple roles 
for TALPID3. We still have little understanding of the action of TALPID3 in regulation of the 
cytoskeleton or cell polarity. It is likely that these outstanding questions are in fact one and the 
same and that in combining the power of human genetics with proteomics, microscopy and 
model systems we will generate new insights into this enduring biological problem and 
illuminate the connection between cell biology and phenotype, towards, we hope, informing 
the development of future therapies for those living with Joubert syndrome and other 
ciliopathies. 
In memory of Dr Donald A. Ede, discoverer of the talpid3 chicken mutant 4th May 1926-22nd 
August 2018. 
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PHENOTYPE Ciliopathy 
Phenotype 
TALPID3 
Animal 
Model 
Short-Rib 
Polydacyly 
Joubert 
Syndrome 
Hedgehog 
related 
Cell 
polarity 
related  
CELLULAR DEFECTS yes 1, 2, 3, 5, 6, 7 yes     yes 
Cilia absent/reduced, smaller   1, 2, 3, 5, 6, 7 yes Yes [11]   
 
yes 
Abnormal centrosome location   1, 2, 3, 5, 6, 7     
 
yes 
Increase centriolar satellites    1,7     
 
  
Increased centriole length   1,7     
 
  
Failure of Distal Appendage  1 (reduced), 7 CEP164 seen    
Abnormal actin cytoskeleton   1, 7     
 
yes 
Abnormal Hedgehog signalling yes 1,2,3,5 yes   yes   
FACE AND HEAD DEFECTS yes 5 yes yes yes yes 
Frontonasal prominence yes 1,2 yes yes yes   
Hypotelorism yes 1,2,5   yes yes   
Midface shortening yes 
 
  yes 
 
  
Long philtrum   
 
  yes 
 
  
Mandibular prominence yes 1,2   yes yes   
Micrognathia yes 1   yes yes   
Retrognathia yes 1 yes   
 
  
Cleft tongue yes 
 
yes   
 
  
Abnormal dentition yes 
 
yes yes yes   
Maxillary prominence   1,2 yes   yes   
Cleft palate yes 
 
yes   
 
  
Abnormal dentition yes 
 
  yes yes   
CNS DEFECTS yes 1,2,3,5   yes yes   
Hydrocephaly yes 3 yes yes 
 
  
Enlarged ventricles yes 3 yes yes 
 
  
Forebrain yes 2,3 yes   yes   
Holoprosencephaly yes 1,2,5     yes   
Cerebellum yes 3 yes yes yes   
Molar tooth sign yes 
 
yes yes yes   
Hypoplasia of the cerebellum yes 3 yes yes yes   
Reduced cerebellar foliation yes 3   yes yes   
Reduced sup. cerebellar 
peduncles 
yes 3   yes yes   
Reduced decussation of the 
cerebellar peduncles 
yes 3   yes yes yes 
Loss of granule layer   3     yes   
Disorganised Purkinje cells   3     
 
yes 
Eyes yes 1   yes 
 
  
Coloboma yes 6   yes 
 
  
Retinal degeneration yes 6     
 
  
Loss of photoreceptor polarity   6     
 
yes 
Behaviours yes 3 NA yes 
 
  
Ataxia yes 3   yes 
 
  
Hypotonia yes 
 
  yes 
 
  
Irregular breathing yes 
 
  yes 
 
  
Intellectual disability yes 
 
  yes 
 
  
SKELETAL DEFECTS yes 1,4,5 yes yes yes   
Polydactyly yes 1,2,5 yes   
 
  
Syndactyly yes 1,2     
 
yes 
Failure of ossification yes 1,4     
 
  
Shortened long bones yes 1,4 yes ? yes yes 
Short ribs yes 1 yes rare 
 
  
VISCERA DEFECTS yes 1     yes   
Abnormal situs yes 2,5,6     yes   
Heart defects yes 
 
  rare 
 
  
Kidney cysts yes 1,5   rare 
 
yes 
Small lungs yes 1   rare yes   
Hepatic fibrosis yes 1     yes   
Table 1- An abbreviated review of the phenotypes associated with a loss of 
TALPID3/KIAA0586 [1-5, 7-15, 17, 18, 20, 22, 23, 26, 27, 31, 34-38] 
  
Figure and Table Legends 
Table 1- An abbreviated review of the phenotypes associated with a loss of 
TALPID3/KIAA0586 [1-5, 7-15, 17, 18, 20, 22, 23, 26, 27, 31, 34-38] 
1-7 indicate TALPID3 mutant alleles in model systems. 1=talpid3 chicken (null), 2= Talpid3-/- 
mouse (null), 3=Nestin-cre (null central nervous system), 4=Prx-cre (null in limb), 5=Maternal 
Zygotic talpid3-/- zebrafish (null), 6=Zygotic ta3-/- zebrafish (hypomorph/progressive loss), 7= 
siRNA Knockdown and CRISPR/Cas9 generated KIAA0586-/-, human cells. CNS= central 
nervous system, NA= not appliciable, ?= unclear phenotype. Short Rib Polydactyly and Joubert 
Syndrome refer to the phenotypes observed in human patients with mutations in 
TALPID3/KIAA0586. 
 
  
  
Figure 1- The phenotypes associated with a loss of TALPID3 in the cell, embryo and 
human. Figure 1A. The phenotypes associated with TALPID3 are primarily caused by a loss 
of centrosome (red arrow) function and a loss of the cilia (yellow arrow)- an organelle 
dependent on normal centrosome function. Abnormal cellular phenotypes oberved in null 
TALPID3 cells in culture and in the embryo are as listed. Homozygous null alleles cause an 
embryonic lethal phenotype in humans, mice, zebrafish and chicken embryos, characterised by 
the phenotypes listed and include those associated with disrupted Hedgehog signalling as well 
as phenotype which are independent of Hedgehog signalling. Figure 1B. In comparison with 
null embronic lethal phenotypes, viable humans with  mutations in TALPID3 are likely to have 
hypomorphic mutations, which are usually compound heterozygous mutations. Common 
phenotypes in these patients include brain defects related to the cerebellum and associated 
structures (red arrows), presenting as a ‘Molar Tooth Sign’ which is characteristic of Joubert 
syndrome. More rarely a proportion of patients present with other ‘ciliopathy’ related 
phenotypes, such as polydactyly and other phenotypes listed. 
  
 
Figure 2.- The mutations in TALPID3/KIAA0586 which cause human disease  
Figure 2. Human TALPID3/KIAA0586 mutations can be grouped into three main categories 
rare Lethal short-rib polydactyly (n=2; both are homozygous patients), rare Joubert syndrome 
with addition ciliopathy phenotypes (annotated above the gene structure) and relatively mild 
compound heterozygous mutations which cause Joubert syndrome (anotated below the gene 
structure). Green arrows heads represent rare single deleterious mutations, 
c.2663_2667delp.L888Qfs*24 has been shown to be essential for CP110 removal [26]. A 
hotspot for Joubert syndrome mutations, immediately prior to the essential coiled coil domain 
(blue asterisk) is shown in greater detail. The most common mutation, c.428delG,pR143Kfs*4, 
is annotated in bold and the potential alternative transcriptional start is shown by the blue arrow. 
Heterozygous mutations which do not occur with the common variant are marked by black 
  
arrowheads. The mutations are annotated on a schematic of the human KIAA0586 protein. 
Black vertical lines represent exon boundaries, purple boxes mark the coiled coil domains, red 
vertical lines indicate mutations predicted to result in premature stop codons, grey vertical lines 
represent predicted splice variant mutations. 
  
  
 
Figure 3- Model of the function of TALPID3 in the centrosome and the centrosome 
phenotypes caused by a loss of TALPID3 
(A). TALPID3 interacts with CEP120 and C2CD3 to establish a TALPID3, C2CD3 and OFD1 
complex at the distal ends of the mother and daughter centriole, prior to ciliogenesis. TALPID3 
controls loss of DCP (daughter centriolar proteins; CEP120, CP110, Centrobin, Neurl14) and 
contributes in the acquisition of mother centriolar specific proteins (CEP83, CEP89, FBF1 
module), distal appendage development including localisation of CEP164 (with C2CD3 and 
CEP120) and ciliary vescile binding (with Rab8a) during the maturation of the mother centriole 
towards ciliogenesis.TALPID3 binds to CP110, limiting localisation of CP110 on the mother 
centriole and limiting the length of daughter centriole length.  PCM1 and C2CD3 are found in 
a low number of centriolar satellites around the centrioles B. A loss of TALPLID3 localisation 
from the centrioles results in a loss of C2CD3 and OFD1 and CEP120 is maintained at higher 
  
daughter centriolar levels. Daughter centriolar proteins are maintained and localisation of 
mother centriolar proteins fails. While subdistal appendages develop, distal appendages are 
abnormal, CEP164 is disorganised, ciliary vesicles fail to dock. CP110 is also maintained at 
daughter centriolar levels and centrioles are elongated. Centrioles fail to migrate of orientate 
correctly to the cell surface. Centriolar satillites are abundant and inclide localisation of PCM1 
and Cep290. * indicates known protein interaction with TALPID3.C, C’. Super resolution 
image and reconstruction of TALPID3 localisation (arrows, red) at the distal end of the 
centrosome via Tublin (green).  
  
  
PHENOTYPE 
Ciliopathy 
phenotype 
Null 
TALPID3 
Animal 
Model 
Human 
Short-Rib 
Polydacyly 
Human 
Joubert 
Syndrome 
Hedgehog 
related 
Cell 
polarity 
related 
defect 
CELLULAR DEFECTS yes 1, 2, 3, 5, 6, 
7 
yes     yes 
Cilia absent or ciliated cells 
significantly reduced, size reduced 
  1, 2, 3, 5, 6, 
7 
yes  Yes [11] causative 
of loss HH 
yes 
Abnormal centrosome/basal body 
location 
  1, 2, 3, 5, 6, 
7 
    
 
yes 
 Loss basal body subdistal 
appendage/markers (CEP164, 
CP120) 
  7     
 
  
Increase centriolar satellites    1,7     
 
  
Increased centriole length   1,7     
 
  
Failure of Distal Appendage  1 (reduced, 
CEP164 
seen but 
abnormal), 
7 (no 
CEP164) 
CEP164 
seen 
   
Abnormal microtubule 
cytoskeleton 
  1     
 
yes 
Abnormal actin cytoskeleton   1,7     
 
yes 
Mislocation of Golgi    1     
 
yes 
Mislocation of mitochondria   1,6     
 
yes 
Abnormal cell migration   1,2,3     
 
yes 
Abnormal Hedgehog signalling 
(loss PTC1, GLI1 expression, 
mislocation of GLI protein) 
yes 1,2,3,5 yes   yes   
Abnormal Wnt signalling yes 3     
 
  
FACE AND HEAD DEFECTS yes 5 yes yes yes yes 
Frontonasal prominence yes 1,2 yes yes yes   
Hypotelorism yes 1,2,5   yes yes   
Midface shortening yes 
 
  yes 
 
  
Long philtrum   
 
  yes 
 
  
Mandibular prominence yes 1,2   yes yes   
Micrognathia yes 1   yes yes   
Retrognathia yes 1 yes   
 
  
Cleft tongue yes 
 
yes   
 
  
Abnormal dentition yes 
 
yes yes yes   
Maxillary prominence   1,2 yes   yes   
Cleft palate yes 
 
yes   
 
  
Abnormal dentition yes 
 
  yes yes   
Pituitary gland absence   1     yes   
CENTRAL NERVOUS 
SYSTEM DEFECTS 
yes 1,2,3,5   yes yes   
Hydrocephaly yes 3 yes yes 
 
  
Enlarged ventricles yes 3 yes yes 
 
  
Forebrain yes 2,3 yes   yes   
Holoprosencephaly yes 1,2,5     yes   
Midbrain yes 1     yes   
Expansion of midbrain boundaries yes 1,3     yes   
Hindbrain   1,3     yes   
Cerebellum yes 3 yes yes yes   
Molar tooth sign yes 
 
yes yes yes   
Hypoplasia of the cerebellum yes 3 yes yes yes   
Reduced cerebellar foliation yes 3   yes yes   
Reduced superior cerebellar 
peduncles 
yes 3   yes yes   
Reduced decussation of the 
cerebellar peduncles 
yes 3   yes yes yes 
Loss of granule layer   3     yes   
Disorganised Purkinje 
cells/abberrant connectivity 
  3     
 
yes 
Spinal cord yes 2,5     yes   
Loss of ventral Hh dependent 
neurons 
yes 1,2,5     yes   
Expansion dorsal neurons yes 1,2     yes   
Eyes yes 1   yes 
 
  
Coloboma yes 6   yes 
 
  
Retinal degeneration yes 6     
 
  
  
Supplementary Table1. A comprehensive review of the phenotypes associated with a loss 
of TALPID3/KIAA0586 [1-5, 7-15, 17, 18, 20, 22, 23, 26, 27, 31, 34-38] 
1-7 indicate TALPID3 mutant alleles in model systems. 1=talpid3 chicken (null), 2= Talpid3-/- 
mouse (null), 3=Nestin-cre (null central nervous system), 4=Prx-cre (null in limb), 5=Maternal 
Zygotic talpid3-/- zebrafish (null), 6=Zygotic ta3-/- zebrafish (hypomorph/progressive loss), 7= 
siRNA Knockdown and CRISPR/Cas9 generated KIAA0586-/-, human cells. CNS= central 
nervous system, NA= not appliciable, ?= unclear phenotype. Short Rib Polydactyly and Joubert 
Syndrome refer to the phenotypes observed in human patients with mutations in 
TALPID3/KIAA0586. 
Loss of photoreceptor polarity   6     
 
yes 
Ectopic lens development   1     
 
  
Loss of stereocilia on hair cells yes 1     
 
yes 
Behaviours yes 3 NA yes 
 
  
Ataxia yes 3   yes 
 
  
Hypotonia yes 
 
  yes 
 
  
Irregular breathing yes 
 
  yes 
 
  
Intellectual disability yes 
 
  yes 
 
  
AXIAL AND APPENDICULAR 
SKELETAL DEFECTS 
yes 1,4,5 yes yes yes   
Limb yes 1,2,5 yes yes yes   
Polydactyly yes 1,2,5 yes   
 
  
Syndactyly yes 1,2     
 
yes 
Shortened/curled body axis partly 1,5     yes yes 
Skeleton yes 1,4 yes   yes   
Failure of ossification yes 1,4     
 
  
Mislocation of cell polarity marker 
(VANGL2) 
  1     
 
yes 
Misorientation of chondrocytes   1     
 
yes 
Shortened long bones yes 1,4 yes ? yes yes 
Short ribs yes 1 yes rare 
 
  
VISCERA DEFECTS yes 1     yes   
Abnormal situs yes 2,5,6     yes   
Heart defects yes 
 
  rare 
 
  
Kidney cysts yes 1,5   rare 
 
yes 
Small lungs yes 1   rare yes   
Hepatic fibrosis yes 1     yes   
Gut patterning/innervation   1     yes   
MUSCLE DEFECTS   1,5     yes   
Abnormal myotome/muscle 
development 
  1,5     yes   
INTEGUMENTARY DEFECTS 
-Skin/Feather/Hair/Scales/Nails  
  1     yes   
Failure of appendage development   1     yes   
Lost of polarity of appendage   1     
 
yes 
VASCULAR DEFECTS   1,5     yes   
Ectopic blood vessels   1     
 
  
Haemorrhage   1,2,3,5     
 
  
Oedema   1,3         
